ProductUpdated on 16 September 2024
Peptide-ionic liquid conjugates for the prevention and/or treatment of skin disorders
About
The technology concerns new peptide-ionic liquid (PIL) conjugates able to display a triple antibacterial, antifungal, and collagenesis-inducing action. These features make them valuable assets in the future development of topical treatments for complicated skin and soft tissue infections (cSSTI) and other skin disorders where chronic inflammation and a higher risk of infection are present, as well as for cosmetic applications.
Similar opportunities
Product
Nicholas HSU
Global Account Manager at Anti-Microbial Savior BioteQ Co. Ltd.
Kaohsiung City, Taiwan
Service
Clinical trials and Pilots for assessing mental health
Eduardo Sampaio
CEO at Psychomeasure
Ilhavo, Portugal
Expertise
- Digital Health
- Horizontal Applications
Panos Athanasiadis
Project Manager at Allweb Solutions
Chalkida, Greece